amylin vs glp-1 What is the pipeline for future medications for obesity? Amycretin — a novel obesity

Month Maintenance (2.2mg): Ongoing maintenance $1,297

We comprehensively mapped the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound)

a Google Sheets labeled tracker is included, though some Excel formatting may display slightly differently in Sheets

Every batch is tested and must meet the requirements of USP 797.1

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats of the blockbuster drugs.

GLP-1 drugs cause rapid weight loss, which for some users comes with unexpected and less desirable side effects, such as an altered sense of smell and taste, sagging skin, wrinkles, muscle mass loss, and bad breath